Metabolic Syndrome

A wake-up call

Marc Rendell, David Gurwitz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Metabolic Syndrome, already affecting over 40% of the US population over the age of 60, is fast becoming "the plague of the 21st century" in developed nations. The time has come for health system policymakers to prioritize the fight against Metabolic Syndrome and its associated morbidity. We need an aggressive effort and funding for better early diagnosis, educational programs and assistance for lifestyle changes, basic research, as well as novel drug development programs. Failing in this effort, we are doomed to witness further increases in morbidity from associated diseases, ranging from type 2 diabetes to coronary heart disease and stroke, with these events taking place at younger ages. The cost to society is projected to be so high that it justifies an effort at least similar in magnitude to past and current drives for fighting cancer, drug abuse, and AIDS. Sadly, it seems that so far we have fallen behind in our battle against Metabolic Syndrome. We call upon government and industry leaders to wake up and engage the fight against Metabolic Syndrome and its associated diseases. The clock is ticking and the cost to society is escalating.

Original languageEnglish
Pages (from-to)535-538
Number of pages4
JournalDrug Development Research
Volume67
Issue number7
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Medical problems
Morbidity
Costs and Cost Analysis
Pharmaceutical Preparations
Plague
Costs
Clocks
Developed Countries
Health
Type 2 Diabetes Mellitus
Substance-Related Disorders
Coronary Disease
Life Style
Early Diagnosis
Industry
Acquired Immunodeficiency Syndrome
Stroke
Research
Population
Neoplasms

All Science Journal Classification (ASJC) codes

  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Metabolic Syndrome : A wake-up call. / Rendell, Marc; Gurwitz, David.

In: Drug Development Research, Vol. 67, No. 7, 07.2006, p. 535-538.

Research output: Contribution to journalArticle

Rendell, M & Gurwitz, D 2006, 'Metabolic Syndrome: A wake-up call', Drug Development Research, vol. 67, no. 7, pp. 535-538. https://doi.org/10.1002/ddr.20118
Rendell, Marc ; Gurwitz, David. / Metabolic Syndrome : A wake-up call. In: Drug Development Research. 2006 ; Vol. 67, No. 7. pp. 535-538.
@article{b642ded6df8b46d39683263d25178c47,
title = "Metabolic Syndrome: A wake-up call",
abstract = "Metabolic Syndrome, already affecting over 40{\%} of the US population over the age of 60, is fast becoming {"}the plague of the 21st century{"} in developed nations. The time has come for health system policymakers to prioritize the fight against Metabolic Syndrome and its associated morbidity. We need an aggressive effort and funding for better early diagnosis, educational programs and assistance for lifestyle changes, basic research, as well as novel drug development programs. Failing in this effort, we are doomed to witness further increases in morbidity from associated diseases, ranging from type 2 diabetes to coronary heart disease and stroke, with these events taking place at younger ages. The cost to society is projected to be so high that it justifies an effort at least similar in magnitude to past and current drives for fighting cancer, drug abuse, and AIDS. Sadly, it seems that so far we have fallen behind in our battle against Metabolic Syndrome. We call upon government and industry leaders to wake up and engage the fight against Metabolic Syndrome and its associated diseases. The clock is ticking and the cost to society is escalating.",
author = "Marc Rendell and David Gurwitz",
year = "2006",
month = "7",
doi = "10.1002/ddr.20118",
language = "English",
volume = "67",
pages = "535--538",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Metabolic Syndrome

T2 - A wake-up call

AU - Rendell, Marc

AU - Gurwitz, David

PY - 2006/7

Y1 - 2006/7

N2 - Metabolic Syndrome, already affecting over 40% of the US population over the age of 60, is fast becoming "the plague of the 21st century" in developed nations. The time has come for health system policymakers to prioritize the fight against Metabolic Syndrome and its associated morbidity. We need an aggressive effort and funding for better early diagnosis, educational programs and assistance for lifestyle changes, basic research, as well as novel drug development programs. Failing in this effort, we are doomed to witness further increases in morbidity from associated diseases, ranging from type 2 diabetes to coronary heart disease and stroke, with these events taking place at younger ages. The cost to society is projected to be so high that it justifies an effort at least similar in magnitude to past and current drives for fighting cancer, drug abuse, and AIDS. Sadly, it seems that so far we have fallen behind in our battle against Metabolic Syndrome. We call upon government and industry leaders to wake up and engage the fight against Metabolic Syndrome and its associated diseases. The clock is ticking and the cost to society is escalating.

AB - Metabolic Syndrome, already affecting over 40% of the US population over the age of 60, is fast becoming "the plague of the 21st century" in developed nations. The time has come for health system policymakers to prioritize the fight against Metabolic Syndrome and its associated morbidity. We need an aggressive effort and funding for better early diagnosis, educational programs and assistance for lifestyle changes, basic research, as well as novel drug development programs. Failing in this effort, we are doomed to witness further increases in morbidity from associated diseases, ranging from type 2 diabetes to coronary heart disease and stroke, with these events taking place at younger ages. The cost to society is projected to be so high that it justifies an effort at least similar in magnitude to past and current drives for fighting cancer, drug abuse, and AIDS. Sadly, it seems that so far we have fallen behind in our battle against Metabolic Syndrome. We call upon government and industry leaders to wake up and engage the fight against Metabolic Syndrome and its associated diseases. The clock is ticking and the cost to society is escalating.

UR - http://www.scopus.com/inward/record.url?scp=33845229167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845229167&partnerID=8YFLogxK

U2 - 10.1002/ddr.20118

DO - 10.1002/ddr.20118

M3 - Article

VL - 67

SP - 535

EP - 538

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 7

ER -